Patent Assignment
Reel/Frame 059636/0984
Assignment of Assignor's Interest
Recorded: 2022-04-19
Pages: 5
Assignor
AGRAWAL, ARVIND
Executed: 2019-10-09
Assignee
OPIANT PHARMACEUTICALS, INC.
201 SANTA MONICA BLVD., SUITE 500, SANTA MONICA, CALIFORNIA, 90401
Covered Property
(1)
Compositions, Devices, and Methods for the Treatment of Overdose and Reward-Based Disorders
Application:
16/721,872 →
Publication:
US 2020/0390691
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 6, 2020
From: CRYSTAL, ROGER; ELLISON, MARK; SKOLNICK, PHIL
To: OPIANT PHARMACEUTICALS, INC.
Reel/Frame 053419/0829 →
Assignment of Assignor's Interest
Aug 6, 2020
From: MAGGIO, EDWARD T.
To: AEGIS THERAPEUTICS, LLC
Reel/Frame 053419/0262 →
Security Interest
Dec 10, 2020
From: OPIANT PHARMACEUTICALS, INC.
To: PONTIFAX MEDISON FINANCE GP, L.P.
Reel/Frame 054602/0192 →
Security Interest
Aug 6, 2021
From: NEURELIS, INC.; AEGIS THERAPEUTICS, LLC
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
Reel/Frame 057111/0242 →
Release of Security Interest
Mar 9, 2023
From: PONTIFAX MEDISON FINANCE GP, L.P.
To: OPIANT PHARMACEUTICALS, INC.
Reel/Frame 062937/0311 →
Assignment of Assignor's Interest
Jun 14, 2023
From: OPIANT PHARMACEUTICALS, INC.
To: INDIVIOR UK LIMITED
Reel/Frame 063944/0323 →
Release of Security Interest
Nov 14, 2024
From: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
To: NEURELIS, INC.; AEGIS THERAPEUTICS, LLC
Reel/Frame 069359/0921 →